The deadline for responding to California's cease-and-desist letters passed last week, and it's shaping up to be an interesting time. Of the 13 companies targeted, several have already packed up, while two biggies have decided to put up a fight.
...and receive Daily News bulletins.
Already have an account?Login Now.
The UK's Nuffield Council on Bioethics says genetically modifying human embryos could be morally permissible, according to the Guardian.
A new Nature Biotechnology paper reports that CRISPR-Cas9 gene editing can lead to large deletions or complex rearrangements that could be pathogenic.
The Wall Street Journal likens a prototype developed by Synthetic Genomics to a "biological fax machine."
In PNAS this week: strategy for reactivating Rett syndrome-linked MECP2, small molecules able to suppress Staphylococcus aureus virulence, and more.